Your session is about to expire
← Back to Search
Behavioural Intervention
Assistive Technology for Children on Tube Feeding
N/A
Recruiting
Led By Sarah Sobotka, MD, MSCP
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Under 3 years of age
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 month, 6 month and exit at 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test an intervention program for children with feeding tubes and tracheostomies to help them transition to oral feeding. The program combines in-home assessments with virtual therapies led by a team
Who is the study for?
This trial is for children with feeding tubes and tracheostomies who need help transitioning to oral feeding. It's designed for those who could benefit from an interdisciplinary approach involving in-home assessments and virtual therapies by a team of specialists.
What is being tested?
The study tests a hybrid intervention combining in-person and virtual support to improve oral feeding. It includes sessions with occupational therapists, speech/language pathologists, dietitians, family liaisons, and a project leader specialized in pediatric care.
What are the potential side effects?
Since the therapy techniques are standard care within professional practice parameters, significant side effects aren't anticipated. However, as this method involves novel virtual elements being researched, unexpected challenges may arise.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am under 3 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 month, 6 month and exit at 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 month, 6 month and exit at 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in percentage of oral calories
Secondary study objectives
Caregiver self-efficacy
Change in Oral Feeding
Increased frequency of feeding trials
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment2 Interventions
All participants in the intervention group will be invited to weekly virtual group therapy mealtime sessions with the Speech-Language Pathologist and other participants in the intervention group. Additionally, families will engage in virtual therapy sessions at least biweekly focused on individualized goals informed by the expertise of the study team and published expert programs. Individualized programs will include virtual sessions with the occupational therapist, speech therapist, or combined therapies. The team will consult with the registered dietitian and Developmental and Behavioral Pediatrician as needed.
Group II: Control groupExperimental Treatment1 Intervention
All participants in the control group will be invited to a weekly virtual group therapy mealtime session with other enrolled control group participants and a speech therapist who is not involved with the intervention. During this informal session, families will have the opportunity to meet other children with feeding tubes and their parents. The investigators will assess level of engagement (frequency of participation) and parental experience at interval assessments. Therapies research participants are already receiving or who begin to receive during the study period (early intervention community therapies, center-based therapies) will not be stopped during this intervention. Data will be collected on the frequency of these standard of care therapies. The assessments used for the control group will be the same assessments as the intervention group and will include the Speech Therapy Assessment; Occupational Therapy Assessment; and Pediatric Eating Assessment Toll.
Find a Location
Who is running the clinical trial?
The Gerber FoundationOTHER
43 Previous Clinical Trials
6,099 Total Patients Enrolled
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
840,094 Total Patients Enrolled
Sarah Sobotka, MD, MSCPPrincipal InvestigatorUniversity of Chicago
1 Previous Clinical Trials
30 Total Patients Enrolled